Phagenesisis a medical device company focusing on the development and marketing of thefirst evidence based clinically proven products for the treatment of neurogenicdysphagia (swallowing dysfunction resulting from brain injury). Dysphagia affects many millions of people in developed markets at any given time and ourproducts are designed to treat these patients using directed neurostimulation to induce compensatory reorganization of the brain. Through fast track development of innovative technology, clinical excellence, managerial experience and operation to the highest levels of quality we intend to establish Phagenesis products as the new gold standard in dysphagia care.
Forgotten password?
Registered?
